Funds holding Cognition Therapeutics Inc
ISIN US19243B1026 · United States
- Fund holders
- 13
- Of which ETFs
- 1 12 other funds
- Value held
- 3.2M $
- Share of capital
- 4.1 % of 95.1M shares on Aug 4, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 2,056,395 | 1.6M $ | 0.00 % | 2.16 % | as of Mar 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 874,810 | 664.4K $ | 0.00 % | 0.92 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 421,387 | 459.3K $ | 0.00 % | 0.44 % | as of Feb 28, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 143,771 | 156.7K $ | 0.00 % | 0.15 % | as of Feb 28, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 112,399 | 122.5K $ | 0.00 % | 0.12 % | as of Feb 28, 2026 ↗ |
| Schwab Total Stock Market Index Fund SCHWAB CAPITAL TRUST | 84,940 | 107K $ | 0.00 % | 0.09 % | as of Apr 30, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 51,054 | 55.6K $ | 0.00 % | 0.05 % | as of Feb 28, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 38,785 | 29.5K $ | 0.00 % | 0.04 % | as of Mar 31, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 31,797 | 24.1K $ | 0.00 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Gabelli Global Mini Mites Fund GAMCO Global Series Funds, Inc | 30,000 | 22.8K $ | 0.10 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Victory Extended Market Index Fund Victory Portfolios III | 9,013 | 11.4K $ | 0.00 % | 0.01 % | as of Apr 30, 2026 ↗ |
| iShares Neuroscience and Healthcare ETF iShares Trust | 4,343 | 5.5K $ | 0.11 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 1,629 | 1.2K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| iShares Neuroscience and Healthcare ETF iShares Trust | 0.11 % | as of Apr 30, 2026 ↗ |
| Gabelli Global Mini Mites Fund GAMCO Global Series Funds, Inc | 0.10 % | as of Mar 31, 2026 ↗ |
| Victory Extended Market Index Fund Victory Portfolios III | 0.00 % | as of Apr 30, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
| Schwab Total Stock Market Index Fund SCHWAB CAPITAL TRUST | 0.00 % | as of Apr 30, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 0.00 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 13 | +1 | 3,860,323 | +9.2 % |
| 2026Q1 | 12 | 0 | 3,533,719 | +24.1 % |
| 2025Q4 | 12 | +6 | 2,846,874 | +76.6 % |
| 2025Q3 | 6 | -3 | 1,612,267 | -0.2 % |
| 2025Q2 | 9 | -2 | 1,615,308 | -2.4 % |
| 2025Q1 | 11 | 0 | 1,655,639 | +2.7 % |
| 2024Q4 | 11 | -1 | 1,612,691 | +12.0 % |
| 2024Q3 | 12 | -1 | 1,440,469 | +18.3 % |
| 2024Q2 | 13 | +2 | 1,217,143 | +20.6 % |
| 2024Q1 | 11 | -1 | 1,009,379 | +4.1 % |
| 2023Q4 | 12 | 969,429 |
Institutional managers
72 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| BIOS Capital Management, LP | 6,000,000 | 4.6M $ | as of Mar 31, 2026 |
| DAVENPORT & Co LLC | 2,892,808 | 2.2M $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 1,117,136 | 848.5K $ | as of Mar 31, 2026 |
| Chescapmanager LLC | 997,029 | 757.2K $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 968,362 | 735.5K $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 920,208 | 699.2K $ | as of Mar 31, 2026 |
| Hilton Capital Management, LLC | 548,950 | 416.9K $ | as of Mar 31, 2026 |
| Dauntless Investment Group, LLC | 431,000 | 327.3K $ | as of Mar 31, 2026 |
| CM Management, LLC | 400,000 | 303.8K $ | as of Mar 31, 2026 |
| JANE STREET GROUP, LLC | 370,140 | 281.1K $ | as of Mar 31, 2026 |
| Sigma Planning Corp | 337,765 | 256.5K $ | as of Mar 31, 2026 |
| STATE STREET CORP | 314,483 | 238.9K $ | as of Mar 31, 2026 |
| AMERICAN FINANCIAL GROUP INC | 205,000 | 155.7K $ | as of Mar 31, 2026 |
| Voss Capital, LP | 200,000 | 151.9K $ | as of Mar 31, 2026 |
| XTX Topco Ltd | 195,803 | 148.7K $ | as of Mar 31, 2026 |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 195,000 | 148.1K $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 168,686 | 128.1K $ | as of Mar 31, 2026 |
| HRT FINANCIAL LP | 152,999 | 116 $ | as of Mar 31, 2026 |
| Texas Capital Bank Wealth Management Services Inc | 123,296 | 93.6K $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 84,940 | 64.5K $ | as of Mar 31, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 80,663 | 61.3K $ | as of Mar 31, 2026 |
| UBS Group AG | 76,873 | 58.3K $ | as of Mar 31, 2026 |
| Corient Private Wealth LLC | 72,112 | 54.8K $ | as of Mar 31, 2026 |
| Virtu Financial LLC | 70,162 | 53 $ | as of Mar 31, 2026 |
| McAdam, LLC | 69,953 | 53.1K $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Funds holding Cognition Therapeutics Inc". https://titelia.com/en/stocks/cognition-therapeutics-inc-US19243B1026